These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 35760047)

  • 1. Progestogen-Mediated Neuroprotection in Central Nervous System Disorders.
    Bassani TB; Bartolomeo CS; Oliveira RB; Ureshino RP
    Neuroendocrinology; 2023; 113(1):14-35. PubMed ID: 35760047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone and Allopregnanolone Neuroprotective Effects in the Wobbler Mouse Model of Amyotrophic Lateral Sclerosis.
    De Nicola AF; Meyer M; Garay L; Kruse MS; Schumacher M; Guennoun R; Gonzalez Deniselle MC
    Cell Mol Neurobiol; 2022 Jan; 42(1):23-40. PubMed ID: 34138412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone and allopregnanolone in the central nervous system: response to injury and implication for neuroprotection.
    Guennoun R; Labombarda F; Gonzalez Deniselle MC; Liere P; De Nicola AF; Schumacher M
    J Steroid Biochem Mol Biol; 2015 Feb; 146():48-61. PubMed ID: 25196185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestins and neuroprotection: are all progestins created equal?
    Singh M
    Minerva Endocrinol; 2007 Jun; 32(2):95-102. PubMed ID: 17557035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestogens and brain: an update.
    Pluchino N; Cubeddu A; Giannini A; Merlini S; Cela V; Angioni S; Genazzani AR
    Maturitas; 2009 Apr; 62(4):349-55. PubMed ID: 19167174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complex molecular changes induced by chronic progestogens exposure in roach, Rutilus rutilus.
    Maasz G; Zrinyi Z; Takacs P; Lovas S; Fodor I; Kiss T; Pirger Z
    Ecotoxicol Environ Saf; 2017 May; 139():9-17. PubMed ID: 28092737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors.
    Schumacher M; Mattern C; Ghoumari A; Oudinet JP; Liere P; Labombarda F; Sitruk-Ware R; De Nicola AF; Guennoun R
    Prog Neurobiol; 2014 Feb; 113():6-39. PubMed ID: 24172649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progesterone and progestins: neuroprotection and myelin repair.
    Schumacher M; Sitruk-Ware R; De Nicola AF
    Curr Opin Pharmacol; 2008 Dec; 8(6):740-6. PubMed ID: 18929681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of the neurosteroid allopregnanolone in a mouse model of spontaneous motoneuron degeneration.
    Meyer M; Garay LI; Kruse MS; Lara A; Gargiulo-Monachelli G; Schumacher M; Guennoun R; Coirini H; De Nicola AF; Gonzalez Deniselle MC
    J Steroid Biochem Mol Biol; 2017 Nov; 174():201-216. PubMed ID: 28951257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Levels and actions of progesterone and its metabolites in the nervous system during physiological and pathological conditions.
    Melcangi RC; Giatti S; Calabrese D; Pesaresi M; Cermenati G; Mitro N; Viviani B; Garcia-Segura LM; Caruso D
    Prog Neurobiol; 2014 Feb; 113():56-69. PubMed ID: 23958466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel perspectives for progesterone in hormone replacement therapy, with special reference to the nervous system.
    Schumacher M; Guennoun R; Ghoumari A; Massaad C; Robert F; El-Etr M; Akwa Y; Rajkowski K; Baulieu EE
    Endocr Rev; 2007 Jun; 28(4):387-439. PubMed ID: 17431228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progesterone and progestins: effects on brain, allopregnanolone and beta-endorphin.
    Pluchino N; Luisi M; Lenzi E; Centofanti M; Begliuomini S; Freschi L; Ninni F; Genazzani AR
    J Steroid Biochem Mol Biol; 2006 Dec; 102(1-5):205-13. PubMed ID: 17052903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone as a neuroactive neurosteroid, with special reference to the effect of progesterone on myelination.
    Baulieu E; Schumacher M
    Steroids; 2000; 65(10-11):605-12. PubMed ID: 11108866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progestogens exhibit progestogen-, promoter- and isoform-specific effects via the progesterone receptor.
    Enfield K; Avenant C; Hapgood JP
    Steroids; 2022 Nov; 187():109094. PubMed ID: 35905833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allopregnanolone-mediated protective effects of progesterone on tributyltin-induced neuronal injury in rat hippocampal slices.
    Ishihara Y; Kawami T; Ishida A; Yamazaki T
    J Steroid Biochem Mol Biol; 2013 May; 135():1-6. PubMed ID: 23280249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroactive steroids, neurosteroidogenesis and sex.
    Giatti S; Garcia-Segura LM; Barreto GE; Melcangi RC
    Prog Neurobiol; 2019 May; 176():1-17. PubMed ID: 29981391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the potential of natural and synthetic neuroprotective steroids against neurodegenerative disorders: A literature review.
    Bansal R; Singh R
    Med Res Rev; 2018 Jul; 38(4):1126-1158. PubMed ID: 28697282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progestogen metabolism.
    Lobo RA
    J Reprod Med; 1999 Feb; 44(2 Suppl):148-52. PubMed ID: 11392024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The other side of progestins: effects in the brain.
    Giatti S; Melcangi RC; Pesaresi M
    J Mol Endocrinol; 2016 Aug; 57(2):R109-26. PubMed ID: 27339142
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of clinically relevant progestins on the neural effects of estradiol and the signaling pathways involved.
    Nilsen J; Deng J; Brinton RD
    Drug News Perspect; 2005 Nov; 18(9):545-53. PubMed ID: 16421627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.